Dose-response curve

Definition

A dose-response curve is a graphical representation of the relationship between the dose (amount) of a compound and the magnitude of the biological response it produces. Dose-response curves typically show dose on the x-axis (often on a logarithmic scale) and response on the y-axis. The curve rises from zero response at low doses, reaches a maximum response at higher doses, and may decline at very high doses if toxicity occurs. Key parameters derived from dose-response curves include the ED50 (effective dose that produces 50% of the maximum response) and the TD50 (toxic dose that produces toxicity in 50% of exposed animals). The slope of the dose-response relationship indicates how steeply response increases with dose; steep slopes indicate that small dose changes produce large response changes, while shallow slopes indicate more gradual changes. Understanding the dose-response curve for a peptide is essential for establishing appropriate therapeutic doses, predicting how dose adjustments will affect response, and identifying the dose range where beneficial effects occur with acceptable side effects. In research, dose-response studies systematically test multiple dose levels and characterize the shape and parameters of the dose-response curve.

Dose-response curves often follow a sigmoidal (S-shaped) pattern when plotted on a linear scale, or become linear when plotted on a logarithmic dose scale. This mathematical relationship is described by the Hill equation, which characterizes the maximum response (Emax), the dose producing 50% of maximum response (EC50), and the slope (Hill coefficient). The Hill coefficient reflects the cooperativity of the response; a coefficient of 1 indicates simple first-order kinetics, while coefficients greater than 1 indicate cooperative or synergistic interactions.

Dose-response relationships vary between individuals due to differences in pharmacokinetics, genetics, age, weight, and concomitant medications. A population dose-response curve represents the average response across many individuals; individual dose-response curves may be shifted to the right (requiring higher doses to achieve the same response) or left (requiring lower doses) compared to the population average. This variability means that the same dose may produce different responses in different people. Clinical trials measure dose-response relationships in humans to establish optimal dosing, and regulatory submissions include dose-response data demonstrating that the proposed dose produces a beneficial effect with acceptable risks.